REVERSIBLE NEUROTOXICITY DURING INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA

被引：3
作者：
VANLAAR, JM
VANBUCHEM, MA
WEYL, N
CLETON, FJ
机构：
[1] UNIV LEIDEN HOSP,DEPT RADIOL,2300 RC LEIDEN,NETHERLANDS
[2] UNIV LEIDEN HOSP,DEPT ONCOL,2300 RC LEIDEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷 / 11期
关键词：
D O I：
10.1016/0959-8049(95)00297-V
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1895 / 1897
页数：3
相关论文
共 50 条
[21]   RECOMBINANT INTERFERON-ALPHA-2A AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA [J].
JURINCICWINKLER, C ;
HORLBECK, R ;
KLIPPEL, KF .
WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (10) :271-276
[22]   SELECTION OF CANDIDATES FOR NEPHRECTOMY AND TIMING OF INTERLEUKIN-2 THERAPY AFTER SURGERY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA [J].
ROBERTSON, CN ;
MARSTON, W .
JOURNAL OF UROLOGY, 1987, 137 (04) :A332-A332
[23]   Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma [J].
Dutcher, J .
ONCOLOGY-NEW YORK, 2002, 16 (11) :4-10
[24]   METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING [J].
FARACE, F ;
PALLARDY, M ;
ANGEVIN, E ;
HERCEND, T ;
ESCUDIER, B ;
TRIEBEL, F .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (06) :814-821
[25]   THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA BY CONTINUOUS INTRAVENOUS-INFUSION OF RECOMBINANT INTERLEUKIN-2 [J].
GORE, ME ;
GALLIGIONI, E ;
KEEN, CW ;
SORIO, R ;
LORIAUX, EM ;
GROBBEN, HC ;
FRANKS, CR .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (03) :329-333
[26]   Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma [J].
Fallick, ML ;
McDermott, DF ;
LaRock, D ;
Long, JP ;
Atkins, MB .
JOURNAL OF UROLOGY, 1997, 158 (05) :1691-1695
[27]   INTERLEUKIN-2 THERAPY FOR ADVANCED RENAL-CELL CARCINOMA - RADIOGRAPHIC EVALUATION OF RESPONSE AND COMPLICATIONS [J].
DAVIS, SD ;
BERKMEN, YM ;
WANG, JCL .
RADIOLOGY, 1990, 177 (01) :127-131
[28]   Natural history and therapy of metastatic renal cell carcinoma - The role of interleukin-2 [J].
Bukowski, RM .
CANCER, 1997, 80 (07) :1198-1220
[29]   HAS INTERLEUKIN-2 MODIFIED THE OUTCOME OF METASTATIC RENAL-CELL CANCER [J].
NEGRIER, S ;
PHILIP, T .
ANNALES D UROLOGIE, 1993, 27 (02) :87-89
[30]   HAS INTERLEUKIN-2 MODIFIED THE OUTCOME OF METASTATIC RENAL-CELL CANCER [J].
NEGRIER, S ;
PHILIP, T .
ANNALES DE CHIRURGIE, 1992, 46 (05) :373-375
12345